<DOC>
	<DOCNO>NCT00041470</DOCNO>
	<brief_summary>The purpose : - To determine high dos Taxol Navelbine safely give patient ; - To determine kind side effect cause combination Taxol , Navelbine G-CSF ; - To determine whether combination Taxol , Navelbine G-CSF effective standard therapy treat metastatic breast cancer prolong life ;</brief_summary>
	<brief_title>Navelbine , Taxol , Herceptin Neupogen Stage IV Breast Cancer : A Phase I - II Trial</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>INCLUSION To eligible , volunteer must : Have stage IV carcinoma breast microscopically confirm Be age &gt; 18 Be fully active ambulatory symptom able light work Have life expectancy &gt; 16 week Be &gt; 2 week prior surgery ; &gt; 3 week radiation therapy pelvis , spine long bone ; &gt; 3 week prior chemotherapy ( &gt; 6 week mitomycin C nitrosureas ) &gt; 2 week prior hormonal therapy Have one less prior regimen metastatic disease Have measurable ( bidimensionally ) evaluable disease area radiate EXCLUSION Patients eligible : Have rapidly progress liver lung metastasis uncontrolled central nervous system metastasis Are medically unstable Are pregnant , nurse unwilling employ adequate contraception Have preexist clinically significant peripheral neuropathy except abnormality due cancer Have psychological , familial , sociological geographical condition permit weekly medical followup compliance study protocol Have hypersensitivity E. Coliderived protein , Filgrastim , component Have prior therapy Navelbine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>